跳至主要内容
临床试验/NCT01964703
NCT01964703已完成4 期

Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes; A Proof-of-concept, Randomized, Double-blind, Parallel-group Placebo-controlled Study

Korea University Anam Hospital0 个研究点目标入组 29 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
29
主要终点
serum glucose (fasting and post 75g oral glucose tolerance test)

研究概览

简要总结

The purpose of this study is to determine whether Rubus occidentalis extract could improve fasting or postprandial serum glucose levels, and related metabolic markers among patients with prediabetes (impaired fasting glucose and/or impaired glucose tolerance).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 years of age or older
  • prediabetes (fasting plasma glucose 100-125mg/dl, and/or post 75g OGTT plasma glucose 140-199mg/dl)

排除标准

  • pregnant women
  • taking anti-hyperglycemic agents within 3 months at the time of enrollment
  • history of heart failure, myocardial infarction, cerebral infarction
  • uncontrolled hypertension (systolic BP > 160mmHg, or diastolic BP > 100mmHg)
  • serum triglyceride level > 500mg/dl
  • kidney dysfunction (serum Creatinine > 30% of upper normal limits)
  • hepatic dysfunction (AST, ALT > 3 times of upper normal limits)
  • taking systemic glucocorticoids within 1 month

研究组 & 干预措施

Rubus occidentalis extract 900mg

Active Comparator

taking Rubus occidentalis extract 900mg/day for 12weeks

干预措施: Rubus occidentalis extract (Drug)

Rubus occidentalis extract 1800mg

Active Comparator

taking Rubus occidentalis extract 1800mg/day for 12weeks

干预措施: Rubus occidentalis extract (Drug)

结局指标

主要结局

serum glucose (fasting and post 75g oral glucose tolerance test)

时间窗: 12 weeks

次要结局

  • serum insulin(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sin Gon Kim

Professor

Korea University Anam Hospital

相似试验